Affimed (NASDAQ: AFMD) reported Q2 EPS of (EUR0.20), EUR0.01 worse than the analyst estimate of (EUR0.19). Revenue for the quarter came in at EUR1.39 million versus the consensus estimate of EUR4.27 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.